Ratings by B.Riley (William Wood)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/20/2026 | Alpha Cognition Inc | ACOG | New Coverage | Buy (N/A) |
8.57 (8.31) |
-3.03% | Details | |
| 7/23/2026 | Agomab Therapeutics | AGMB | New Coverage | Buy (N/A) |
11.60 (9.26) |
-20.17% | Details | |
| 6/5/2026 | iBio, Inc. | IBIO | New Coverage | Buy (N/A) |
1.93 (1.20) |
-37.82% | Details | |
| 5/22/2026 | Immunic Inc. | IMUX | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2026 | Aardvark Therapeutics Inc | AARD | Maintain | Buy (N/A) |
|
Details | ||
| 4/16/2026 | Equillium | EQ | New Coverage | Buy (N/A) |
2.05 (1.27) |
-38.05% | Details | |
| 3/24/2026 | Aardvark Therapeutics Inc | AARD | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2026 | Aardvark Therapeutics Inc | AARD | New Coverage | Buy (N/A) |
14.76 (3.95) |
-73.24% | Details | |
| 1/9/2026 | Palisade Bio Inc. | PALI | New Coverage | Buy (N/A) |
2.02 (1.35) |
-33.17% | Details | |
| 12/7/2025 | OKYO Pharma Ltd. | OKYO | New Coverage | Buy (N/A) |
2.01 (1.47) |
-26.87% | Details | |
| 9/2/2025 | Immunic Inc. | IMUX | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2025 | Immunic Inc. | IMUX | Maintain | Buy (N/A) |
|
Details | ||
| 8/27/2024 | Immunic Inc. | IMUX | New Coverage | Buy (N/A) |
1.46 (7.22) |
394.52% | Details | |
| 8/8/2024 | LifeMD Inc | LFMD | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2024 | Veru, Inc. | VERU | New Coverage | Buy (N/A) |
1.33 (2.29) |
72.18% | Details | |
| 3/12/2024 | LifeMD Inc | LFMD | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2023 | Koru Medical Systems Inc. | KRMD | New Coverage | Buy (N/A) |
2.30 (3.08) |
33.91% | Details | |
| 12/1/2023 | Clearpoint Neuro Inc. | CLPT | New Coverage | Buy (N/A) |
5.76 (9.25) |
60.59% | Details | |
| 12/1/2023 | LifeMD Inc | LFMD | New Coverage | Buy (N/A) |
7.70 (2.17) |
-71.82% | Details |
